Katrin Aslan Selected Research

Brain Neoplasms (Brain Tumor)

1/2020

Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katrin Aslan Research Topics

Disease

6	Neoplasms (Cancer) 01/2023 - 01/2020
4	Glioma (Gliomas) 01/2022 - 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Brain Neoplasms (Brain Tumor) 01/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2020

Drug/Important Bio-Agent (IBA)

2	Peptides (Polypeptides)IBA 01/2023 - 01/2022
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 01/2021
2	AntigensIBA 01/2022 - 01/2021
1	HLA-A Antigens (HLA-A)IBA 01/2023
1	Cancer VaccinesIBA 01/2022
1	Amino Acids FDA Link 01/2021
1	Protein Subunit VaccinesIBA 01/2021
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021
1	OvalbuminIBA 01/2021
1	Tryptophan (L-Tryptophan)FDA Link 01/2021
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2020

Therapy/Procedure

2	Immunotherapy 01/2022 - 01/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2023
1	Therapeutics 01/2020